Nav: Home

Blood and urine tests developed to indicate autism in children

February 18, 2018

  • Link found between autism and damage to proteins in blood plasma
  • Could lead to earlier diagnosis of the condition


New tests which can indicate autism in children have been developed by researchers at the University of Warwick.

The academic team who conducted the international research believe that their new blood and urine tests which search for damage to proteins are the first of their kind.

The tests could lead to earlier detection of autism spectrum disorders (ASD) and consequently children with autism could be given appropriate treatment much earlier in their lives.

ASDs are defined as developmental disorders mainly affecting social interaction and they can include a wide spectrum of behavioural problems. These include speech disturbances, repetitive and/or compulsive behaviour, hyperactivity, anxiety, and difficulty to adapt to new environments, some with or without cognitive impairment. Since there is a wide range of ASD symptoms diagnosis can be difficult and uncertain, particularly at the early stages of development.

The paper "Advanced glycation endproducts, dityrosine, and arginine transporter dysfunction in autism -- a source of biomarkers for clinical diagnosis" has been published in Molecular Autism. The team was led by Dr Naila Rabbani, Reader of Experimental Systems Biology at the University of Warwick who said: "Our discovery could lead to earlier diagnosis and intervention."

"We hope the tests will also reveal new causative factors. With further testing we may reveal specific plasma and urinary profiles or "fingerprints" of compounds with damaging modifications. This may help us improve the diagnosis of ASD and point the way to new causes of ASD."

The team which is based at the University's Warwick Medical School involves academics at the University of Warwick's Warwick Systems Biology group, the University of Birmingham, the University of Bologna, the Institute of Neurological Sciences, Bologna, and the Don Carlo Gnocchi Foundation ONLUS. They found a link between ASD and damage to proteins in blood plasma by oxidation and glycation - processes where reactive oxygen species (ROS) and sugar molecules spontaneously modify proteins. They found the most reliable of the tests they developed was examining protein in blood plasma where, when tested, children with ASD were found to have higher levels of the oxidation marker dityrosine (DT) and certain sugar-modified compounds called "advanced glycation endproducts" (AGEs).

Genetic causes have been found in 30-35% of cases of ASD and the remaining 65-70% of cases are thought to be caused by a combination of environmental factors, multiple mutations, and rare genetic variants. However the research team also believe that the new tests could reveal yet to be identified causes of ASD.

The team's research also confirmed the previously held belief that mutations of amino acid transporters are a genetic variant associated with ASD. The Warwick team worked with collaborators at the University of Bologna, Italy, who recruited locally 38 children who were diagnosed as having with ASD (29 boys and nine girls) and a control group of 31 healthy children (23 boys and eight girls) between the ages of five and 12. Blood and urine samples were taken from the children for analysis.

The Warwick team discovered that there were chemical differences between the two groups. Working with a further collaborator at the University of Birmingham, the changes in multiple compounds were combined together using artificial intelligence algorithms techniques to develop a mathematical equation or "algorithm" to distinguish between ASD and healthy controls. The outcome was a diagnostic test better than any method currently available.

The next steps are to repeat the study with further groups of children to confirm the good diagnostic performance and to assess if the test can identify ASD at very early stages, indicate how the ASD is likely to develop further to more severe disease and assess if treatments are working.
-end-
Photocaption: changes found in protein damage and amino acids in ASD

For further details contact Nicola Jones, Media Relations Manager, University of Warwick 07920531221 or N.Jones.1@warwick.ac.uk

Notes to Editors

Title: Advanced glycation endproducts, dityrosine, and arginine transporter dysfunction in autism--a source of biomarkers for clinical diagnosis
Published in:Molecular Autism
DOI 10.1186/s13229-017-0183-3

Authors: Attia Anwar, Warwick Medical School, University of Warwick

Provvidenza Maria Abruzzo, Department of Experimental, Diagnostic and Specialty Medicine, School of Medicine, University of Bologna; Don Carlo Gnocchi Foundation ONLUS, IRCCS "S. Maria Nascente", Milan

Sabah Pasha, Warwick Medical School, University of Warwick

Kashif Rajpoot, Department of Computer Science, University of Birmingham,

Alessandra Bolotta, Department of Experimental, Diagnostic and Specialty Medicine, School of Medicine, University of Bologna; Don Carlo Gnocchi Foundation ONLUS, IRCCS "S. Maria Nascente", Milan; Warwick Systems Biology, University of Warwick, Clinical Sciences Research Laboratories, University Hospital, Coventry

Alessandro Ghezzo, Department of Experimental, Diagnostic and Specialty Medicine, School of Medicine, University of Bologna,

Marina Marini, Department of Experimental, Diagnostic and Specialty Medicine, School of Medicine, University of Bologna; Don Carlo Gnocchi Foundation ONLUS, IRCCS "S. Maria Nascente", Milan,

Annio Posar, Child Neurology and Psychiatry Unit, IRCCS Institute of Neurological Sciences, Bologna; Department of Biomedical and Neuromotor Sciences, University of Bologna

Paola Visconti Child Neurology and Psychiatry Unit, IRCCS Institute of Neurological Sciences, Bologna

Paul J. Thornalley, Warwick Medical School, University of Warwick; Warwick Systems Biology, University of Warwick, Clinical Sciences Research Laboratories, University Hospital, Coventry

Naila Rabbani, Warwick Medical School, University of Warwick; Warwick Systems Biology, University of Warwick, Clinical Sciences Research Laboratories, University Hospital, Coventry; Research Technology Platform-Proteomics, University of Warwick; AGEomics and Systems Biology Research Group, Warwick Systems Biology, University of Warwick, University Hospital, Coventry

This work received the following funding:

Naila Rabbani - Warwick Impact Fund;

Marina Marini - Fondazione del Monte di Bologna e Ravenna, Italy; Fondazione Nando Peretti, Rome, Italy

University of Warwick

Related Autism Articles:

Genes, ozone, and autism
Exposure to ozone in the environment puts individuals with high levels of genetic variation at an even higher risk for developing autism than would be expected just by adding the two risk factors together, a new analysis shows.
A blood test for autism
An algorithm based on levels of metabolites found in a blood sample can accurately predict whether a child is on the autism spectrum of disorder (ASD), based upon a recent study.
New form of autism found
Autism spectrum disorders (ASD) affect around one percent of the world's population and are characterized by a range of difficulties in social interaction and communication.
Autism Speaks MSSNG study expands understanding of autism's complex genetics
A new study from Autism Speaks' MSSNG program expands understanding of autism's complex causes and may hold clues for the future development of targeted treatments.
Paths to Autism: One or Many?
A new report in Biological Psychiatry reports that brain alterations in infants at risk for autism may be widespread and affect multiple systems, in contrast to the widely held assumption of impairment specifically in social brain networks.
Raising a child with autism
Humans are resilient, even facing the toughest of life's challenges.
Explaining autism
Recognizing a need to better understand the biology that produces Autism Spectrum Disorder (ASD) symptoms, scientists at Duke-NUS Medical School (Duke-NUS) and the National Neuroscience Institute (NNI), Singapore, have teamed up and identified a novel mechanism that potentially links abnormal brain development to the cause of ASDs.
Autism breakthrough
Using a visual test that is known to prompt different reactions in autistic and normal brains, Harvard researchers have shown that those differences were associated with a breakdown in the signaling pathway used by GABA, one of the brain's chief inhibitory neurotransmitters.
New options for treating autism
The release of oxytocin leads to an increase in the production of anandamide, which causes mice to display a preference for interacting socially.
The Autism Science Foundation launches the Autism Sisters Project
The Autism Science Foundation, a not-for-profit organization dedicated to supporting and funding autism research, today announced the launch of the Autism Sisters Project, a new initiative that will give unaffected sisters of individuals with autism the opportunity to take an active role in accelerating research into the 'Female Protective Effect.'

Related Autism Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Changing The World
What does it take to change the world for the better? This hour, TED speakers explore ideas on activism—what motivates it, why it matters, and how each of us can make a difference. Guests include civil rights activist Ruby Sales, labor leader and civil rights activist Dolores Huerta, author Jeremy Heimans, "craftivist" Sarah Corbett, and designer and futurist Angela Oguntala.
Now Playing: Science for the People

#521 The Curious Life of Krill
Krill may be one of the most abundant forms of life on our planet... but it turns out we don't know that much about them. For a create that underpins a massive ocean ecosystem and lives in our oceans in massive numbers, they're surprisingly difficult to study. We sit down and shine some light on these underappreciated crustaceans with Stephen Nicol, Adjunct Professor at the University of Tasmania, Scientific Advisor to the Association of Responsible Krill Harvesting Companies, and author of the book "The Curious Life of Krill: A Conservation Story from the Bottom of the World".